The crowd is a beautiful cross-section of Ohio life: night shift workers grabbing breakfast at odd hours, college students fueling late-night study sessions, families making weekend memories, and ...

A lip balm manufacturer forecasts a $5 million jump in cost of goods. They are among a dozen business owners and managers who ...

Microsoft’s AI momentum, recurring income, and 12% Y.O.Y revenue growth signal strength across segments. Learn why MSFT stock ...

You don't have any notifications. Our premium News+ ad-free experience – only $10 more every 4 weeks!

UroGen Pharma's potential remains strong despite market volatility, with promising FDA prospects for UGN-102 & a $5B opportunity. Read more to know why we rate it as a Strong Buy.

As a content creator, I utilize many different platforms to see which one is going to work best for me as I draft articles.